Champions Oncology, Inc.CSBRNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank56
Year-over-Year Change
Year-over-year operating cash flow growth rate
Latest
22.82%
↓ 85% vs avg
Percentile
P56
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
153.84%
Historical baseline
| Period | Value |
|---|---|
| Q1 2026 | 22.82% |
| Q4 2025 | -389.17% |
| Q3 2025 | -91.26% |
| Q2 2025 | 1301.63% |
| Q1 2025 | 273.14% |
| Q4 2024 | -191.00% |
| Q3 2024 | 117.13% |
| Q2 2024 | -97.61% |
| Q1 2024 | -256.03% |
| Q4 2023 | 114.76% |
| Q3 2023 | -462.91% |
| Q2 2023 | -145.07% |
| Q1 2023 | -52.13% |
| Q4 2022 | 1785.13% |
| Q3 2022 | -124.50% |
| Q2 2022 | -81.30% |
| Q1 2022 | 246.66% |
| Q4 2021 | 468.52% |
| Q3 2021 | 110.91% |
| Q2 2021 | -1566.67% |
| Q1 2021 | -84.64% |
| Q4 2020 | 222.94% |
| Q3 2020 | -128.09% |
| Q2 2020 | 812.19% |
| Q1 2020 | -22.50% |
| Q4 2019 | 229.03% |
| Q3 2019 | -210.71% |
| Q2 2019 | -79.17% |
| Q1 2019 | 1790.63% |
| Q4 2018 | -80.95% |
| Q3 2018 | 3633.33% |
| Q2 2018 | -97.98% |
| Q1 2018 | 66.42% |
| Q4 2017 | 113.76% |
| Q3 2017 | -589.45% |
| Q2 2017 | 161.61% |
| Q1 2017 | -368.12% |
| Q4 2016 | 94.38% |
| Q3 2016 | -309.68% |
| Q2 2016 | 17.49% |